AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
JPMorgan Resumes Amgen (AMGN) at Neutral
October 20, 2023 7:09 AM EDTJPMorgan analyst Chris Schott resumes coverage on Amgen (NASDAQ: AMGN) with a Neutral rating and a price target of $270.00.
The analyst comments "We are moving to a Neutral rating on AMGN from Not Rated, with a December 2024 PT of $270 (Neutral rating and December 2023 PT... More
